HIKMA PHARMA

Company Introduction

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company with its headquarters in London, UK. It is a leading provider of high-quality, branded, generic, and injectable pharmaceutical products. The company operates globally, serving markets across the Middle East, North Africa, Europe, and the United States. In India, Hikma Pharmaceuticals maintains a presence primarily focused on research and development, commercial operations, and strategic partnerships, rather than being a major direct manufacturing hub.

Factory or Trader

Hikma Pharmaceuticals is fundamentally a manufacturer.

Hikma Pharmaceuticals is a global pharmaceutical company with a presence and sales operations in India. Its product portfolio includes a wide range of generic and branded medicines.

Key product categories and examples of products generally manufactured or sold by Hikma Pharma include:

1. Injectables

* Pain Management: Examples include Morphine Sulfate Injection, Hydromorphone Hydrochloride Injection, and Fentanyl Citrate Injection.

* Anti-infectives: Examples include Vancomycin Hydrochloride for Injection, Piperacillin and Tazobactam for Injection, and Cefazolin for Injection.

* Cardiovascular: Examples include Amiodarone Hydrochloride Injection and Diltiazem Hydrochloride Injection.

* Central Nervous System: Examples include Midazolam Hydrochloride Injection and Propofol Injectable Emulsion.

* Oncology: A range of chemotherapeutic agents.

2. Generics (Oral Solids and Liquids)

* Hikma offers a broad portfolio of generic oral solids and liquids across various therapeutic areas, such as cardiovascular, anti-infectives, central nervous system, and gastrointestinal conditions. Specific products would vary based on market registration and demand in India.

3. Branded Products

* While Hikma has a significant branded portfolio, especially in the Middle East and North Africa (MENA) region, its branded offerings in India would depend on market strategy. These generally cover therapeutic areas including respiratory, diabetes, cardiovascular, and oncology.